News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
849,946 Results
Type
Article (86650)
Company Profile (703)
Press Release (762591)
Multimedia
Podcasts (135)
Webinars (17)
Section
Business (232744)
Career Advice (4129)
Deals (39738)
Drug Delivery (129)
Drug Development (91035)
Employer Resources (198)
FDA (18140)
Job Trends (17348)
News (396621)
Policy (39779)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (99)
Alliances (56906)
ALS (110)
Alzheimer's disease (1529)
Antibody-drug conjugate (ADC) (179)
Approvals (18088)
Artificial intelligence (359)
Autoimmune disease (32)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (122)
Biotechnology (481)
Bladder cancer (92)
Brain cancer (35)
Breast cancer (365)
Cancer (2804)
Cardiovascular disease (227)
Career advice (3536)
Career pathing (34)
CAR-T (196)
Cell therapy (540)
Cervical cancer (22)
Clinical research (73849)
Collaboration (991)
Company closure (3)
Compensation (612)
Complete response letters (30)
COVID-19 (2892)
CRISPR (58)
C-suite (302)
Cystic fibrosis (113)
Data (2722)
Decentralized trials (2)
Denatured (47)
Depression (62)
Diabetes (320)
Diagnostics (6950)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (115)
Earnings (97399)
Editorial (47)
Employer branding (25)
Employer resources (168)
Events (131005)
Executive appointments (857)
FDA (19690)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (903)
Gene editing (135)
Generative AI (36)
Gene therapy (402)
GLP-1 (880)
Government (5197)
Grass and pollen (6)
Guidances (179)
Healthcare (20906)
Huntington's disease (28)
IgA nephropathy (36)
Immunology and inflammation (165)
Immuno-oncology (6)
Indications (32)
Infectious disease (3061)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (110)
Interviews (813)
IPO (17873)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (50)
Layoffs (576)
Leadership (25)
Legal (10125)
Liver cancer (82)
Lung cancer (398)
Lymphoma (187)
Machine learning (9)
Management (65)
Manufacturing (396)
MASH (90)
Medical device (14673)
Medtech (14678)
Mergers & acquisitions (22504)
Metabolic disorders (855)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (128)
Neuropsychiatric disorders (37)
Neuroscience (2209)
NextGen: Class of 2025 (7686)
Non-profit (5087)
Now hiring (44)
Obesity (451)
Opinion (282)
Ovarian cancer (95)
Pain (108)
Pancreatic cancer (104)
Parkinson's disease (180)
Partnered (25)
Patents (280)
Patient recruitment (133)
Peanut (53)
People (65501)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22803)
Phase II (32069)
Phase III (24143)
Pipeline (1568)
Policy (201)
Postmarket research (3552)
Preclinical (10289)
Press Release (72)
Prostate cancer (133)
Psychedelics (39)
Radiopharmaceuticals (275)
Rare diseases (476)
Real estate (7396)
Recruiting (75)
Regulatory (26935)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (8)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (156)
Series B (105)
Service/supplier (30)
Sickle cell disease (62)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (78)
Tariffs (62)
The Weekly (86)
Vaccines (853)
Venture capitalists (49)
Weight loss (311)
Women's health (45)
Worklife (20)
Date
Today (129)
Last 7 days (810)
Last 30 days (3612)
Last 365 days (35032)
2025 (15485)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (66)
Alaska (7)
Arizona (276)
Arkansas (14)
Asia (50334)
Australia (8851)
California (7266)
Canada (2253)
China (642)
Colorado (309)
Connecticut (324)
Delaware (184)
Europe (115487)
Florida (1066)
Georgia (247)
Hawaii (1)
Idaho (65)
Illinois (699)
India (31)
Indiana (364)
Iowa (16)
Japan (206)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (72)
Maryland (1047)
Massachusetts (5557)
Michigan (264)
Minnesota (455)
Mississippi (3)
Missouri (95)
Montana (32)
Nebraska (26)
Nevada (76)
New Hampshire (72)
New Jersey (2023)
New Mexico (31)
New York (2036)
North Carolina (1200)
North Dakota (10)
Northern California (3136)
Ohio (240)
Oklahoma (16)
Oregon (48)
Pennsylvania (1559)
Puerto Rico (17)
Rhode Island (38)
South America (1653)
South Carolina (31)
South Dakota (1)
Southern California (2675)
Tennessee (118)
Texas (1091)
United States (27501)
Utah (212)
Virginia (194)
Washington D.C. (77)
Washington State (651)
West Virginia (4)
Wisconsin (80)
There are 849,946 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
June 4, 2025
·
1 min read
Press Releases
Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
June 4, 2025
·
5 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025
June 4, 2025
·
1 min read
Press Releases
Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
June 4, 2025
·
6 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025
June 4, 2025
·
2 min read
Press Releases
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2025
June 4, 2025
·
1 min read
Press Releases
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress
June 4, 2025
·
17 min read
Press Releases
Ascletis Announces Phase III Trial of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne, Meets All Endpoints
June 4, 2025
·
9 min read
Press Releases
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer
June 4, 2025
·
13 min read
Press Releases
Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on ‘Bersiporocin’ at ATS 2025, Highlights Global Patient Demographics
June 4, 2025
·
2 min read
1 of 84,995
Next
